BIO vs RVTY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

BIO

70.1
AI Score
VS
BIO Wins

RVTY

47.5
AI Score

Investment Advisor Scores

BIO

Oct 21, 2026
70score
Recommendation
STRONG BUY

RVTY

Oct 21, 2026
48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BIO RVTY Winner
Forward P/E 41.3223 24.1546 RVTY
PEG Ratio 1.1905 0.7337 RVTY
Revenue Growth -0.1% 1.3% RVTY
Earnings Growth 18.7% 1.2% BIO
Tradestie Score 70.1/100 47.5/100 BIO
Profit Margin 8.6% 8.2% BIO
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation STRONG BUY HOLD BIO

Relative Price Performance (Last 90 Days)

BIO 1M: -5.0% · 3M: +13.9% RVTY 1M: +9.3% · 3M: +38.4%

Current Technical Phase

BIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $360.50

RVTY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.4% over 20 days), RSI 63

RSI (14): 63.2 · Price: $156.61

Fundamentals Snapshot

Metric BIO RVTY
Market Cap — —
Forward P/E 37.0 26.6
Trailing P/E 44.9 74.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.5% 0.5%
Operating Margin 0.1% 0.2%
EPS 7.89 2.09
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, BIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.